Sanjay K. Pandey

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

Christine Esau, Scott Davis, Susan Murray et al. · Cell Metabolism · 2006 · 2K citations · Full text

Mir-122 Regulation, Molecular Physiology, Lipid Synthesis +12

Targeting nuclear RNA for in vivo correction of myotonic dystrophy

Thurman M. Wheeler, Andrew J. Leger, Sanjay K. Pandey et al. · Nature · 2012 · 488 citations · Full text

Gene Therapies, Nuclear Rna, Medicine +7

Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance

Cheol Soo Choi, David B. Savage, Ameya Kulkarni et al. · Journal of Biological Chemistry · 2007 · 369 citations · Full text

Plasma Fatty Acids, Pathology, Fatty Liver Disease +18

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†

Xing Yu, Susan F. Murray, Sanjay K. Pandey et al. · Hepatology · 2005 · 298 citations · Full text

Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS

Sarah J. Ross, Alexey S. Revenko, Lyndsey Hanson et al. · Science Translational Medicine · 2017 · 175 citations